HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VP22 mediates intercellular trafficking and enhances the in vitro antitumor activity of PTEN.

Abstract
PTEN acts as a phosphatidylinositol phosphatase with a possible role in the phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Mutations in PTEN are frequent and their presence is associated with poor prognosis in breast cancer, which is the most common type of non-cutaneous malignancy in females. Delivery of the tumor suppressor PTEN gene represents a powerful strategy for breast cancer therapy, but a present limitation of gene therapy is the ability to deliver sufficient quantities of active proteins to target cells. The capacity of HSV-1VP22 fusion proteins to spread from the primary transduced cell to surrounding cells could improve gene therapeutics, particularly in cancer. To assess the potential efficacy of VP22 as a gene therapy for breast cancer, expression vectors for N- and C-terminal PTEN-VP22 fusion proteins were constructed. VP22‑mediated intercellular transport and antitumor efficacy in BT549 (PTEN-null) breast tumor cells were investigated. The results showed that PTEN-VP22 has the same spreading abilities as VP22. In cell proliferation and apoptosis assays, PTEN-VP22 gene transfer induces a stronger anti-proliferative effect and apoptotic activity compared with PTEN gene transfer alone. In addition, VP22 enhanced the PTEN‑mediated decrease in the level of phosphorylated AKT. The results show that PTEN-VP22 can spread in vitro and PTEN-VP22 gene induces significantly greater antitumor activity than the PTEN gene alone. This study confirms the utility of VP22-mediated delivery in vitro and suggests that PTEN-VP22 may have applications in breast cancer gene therapy.
AuthorsXian Yu, Zhengmin Xu, Jun Lei, Tingting Li, Yan Wang
JournalMolecular medicine reports (Mol Med Rep) Vol. 12 Issue 1 Pg. 1286-90 (Jul 2015) ISSN: 1791-3004 [Electronic] Greece
PMID25816150 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Fusion Proteins
  • Viral Structural Proteins
  • herpes simplex virus type 1 protein VP22
  • Proto-Oncogene Proteins c-akt
  • PTEN Phosphohydrolase
  • PTEN protein, human
Topics
  • Apoptosis (genetics)
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Herpesvirus 1, Human (chemistry, genetics)
  • Humans
  • Mammary Glands, Human (metabolism, pathology)
  • Molecular Targeted Therapy (methods)
  • PTEN Phosphohydrolase (genetics, metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors, genetics, metabolism)
  • Recombinant Fusion Proteins
  • Signal Transduction
  • Viral Structural Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: